Capricor Therapeutics has fallen out with its commercial partner for Duchenne muscular dystrophy (DMD) cell therapy deramiocel, Nippon Shinyaku, and …
Pharma Newswire™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC
Capricor Therapeutics has fallen out with its commercial partner for Duchenne muscular dystrophy (DMD) cell therapy deramiocel, Nippon Shinyaku, and …
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Pfizer has …
Following up on President Donald Trump’s April 18th executive order, the US FDA has issued three more Commissioner’s National Priority …
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Johnson & …
Senju Pharma has launched a new drug for dry eye disease (DED) in Japan, Avarept, which is the first drug …
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. AI has …
At BIO-Europe Spring 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Dr Olga Nissan, vice president of business …
After launching a PrEP medication that was 100% effective in clinical trials, the company is facing a complex global rollout …
This week saw both Regenxbio and Solid Bio report new data with their gene therapy candidates for Duchenne muscular dystrophy …
Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. CEO departures …
Pharma Newswire™ aggregates, publishes and distributes news in the Pharmaceutical Industry. In association with EmailWire, Pharma Newswire™ provides press release distribution services in the pharmaceutical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. To send a press release, contact us through the following messaging apps:
Pharma Newswire™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC